
Avicanna Inc experienced a notable uptick in its stock price, closing up 9.52% in yesterday's trading session.
Investors in Avicanna Inc (AVCN.TO) saw positive news as the stock surged by 9.52% yesterday, closing at CA$0.12. This increase reflects growing investor confidence in the company's strategic initiatives and market positioning.
Advertisement
Avicanna Inc
AVCN.TO
AVCN.TO
Avicanna Inc
Market cap
$15.45M
52W high
$0.30
52W low
$0.10
1W change
+9.52%
Beta
0.35
Analyst Price Targets
Based on analyst covering AVCN · as of Sep 17, 2026
Wall Street analysts forecast AVCN stock price to rise 508.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.70
+508.7% Upside
Current Price
C$0.12
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCN's historical volatility
30-Day Vol
94.2%
Annualized
90-Day Vol
80.1%
Annualized
Trend (90d)
-35.0%
Annualized drift
90d Mean
C$0.10
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.11 | C$0.08 – C$0.15 |
| 60 trading days | C$0.11 | C$0.07 – C$0.17 |
| 90 trading days | C$0.10 | C$0.06 – C$0.18 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: The recent surge in Avicanna's stock price highlights the potential for growth in the cannabis sector, especially as the company continues to innovate and expand its healthcare offerings.
Stock Price Climbs to CA$0.12
Avicanna's market cap now stands at approximately CA$15.45 million, reflecting the company's growing presence in the cannabis industry.
Bull case
Avicanna is committed to integrating medical cannabis into Canadian healthcare systems, as shown by their MyMedi.ca program. This positions them well for future growth. Their recent financial results also indicate a positive trajectory, attracting investor interest.
Bear case
Despite the recent gains, Avicanna still faces challenges, including a negative profit margin and the volatility of the cannabis market. Investors should remain cautious and consider the broader market dynamics.
Market Response to Avicanna's Growth Strategy
Advertisement
Avicanna's recent initiatives, especially the launch of the MyMedi.ca Integrated Healthcare Program, have caught the attention of investors. This program aims to seamlessly integrate medical cannabis care into Canadian healthcare institutions, which could drive revenue growth and expand the company's market share.
Financial Performance and Market Position
In its latest financial statements, Avicanna reported record revenue and gross profits, showcasing the effectiveness of its growth strategies. As the company continues to innovate and expand, its stock performance may reflect these positive developments. Investors can explore more about Avicanna's performance on its stock page.
Navigating the Cannabis Market Landscape
While Avicanna's stock has shown positive movement, the cannabis market remains volatile. Investors should consider both the potential for growth and the inherent risks associated with this sector. For further insights, check out Avicanna's latest updates and performance metrics.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement

Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.


